LATEST ALERTS
Members of the Mexican cannabis sector have told CannIntelligence they are pessimistic about whether the framework to regulate the national medical cannabis industry will be implemented before 2024
Tilray Brands continues to show signs of confidence in the future of cannabis-infused drinks by adding more beverage firms to its portfolio and building a distribution network
This report provides a detailed overview of the current regulatory framework in place in Lebanon for hemp, cannabinoids such as CBD, and cannabis
The predicted Red Wave never arrived – but how have the prospects for cannabis-related federal legislation in the US been changed by the midterm elections? US correspondent James DeLise considers the new balance of power in Washington
A cannabis regulation lawyer believes the UK Food Standards Agency (FSA) and the CBD sector have invested so much time, effort and money in the novel food process that it cannot be allowed to fail
In an exclusive partnership with Charlotte’s Web, Major League Baseball (MLB) has become the first of the major US sports leagues to sign a deal with a cannabinoid company
Nearly six months after the European Food Safety Authority (Efsa) put novel food assessments for cannabinoids on hold, none of the validated applicants has been able to fill the identified knowledge gaps
Sweden’s general election in September was not good news for cannabis advocates, with the new right-wing bloc minority government likely to take a highly restrictive view, while cannabinoids are not high on its agenda
The US Food and Drug Administration (FDA) recently appointed Norman Birenbaum to a top post as a senior public health adviser in the FDA’s Center for Regulatory Programs, signalling a seismic shift at the agency
This report provides a detailed overview of the current regulatory framework in place in the Netherlands for hemp, cannabinoids such as CBD and cannabis
US tobacco company 22nd Century Group has enjoyed its first full quarter benefitting from revenue generated by its new hemp/cannabis business arm
Legal hurdles impeding recreational cannabis legalisation in Mexico are expected to continue through 2024, industry members told CannIntelligence during the CannaMexico conference last month
German hemp supplier Signature Products is taking a step back to its roots, saying it will step up its marketing of Ccell vape devices that can be filled with CBD extracts
Austria’s almost non-existent regime for the use of cannabinoids in medication has been described as “a Kafkaesque nightmare” with over-officious bureaucracy putting pointless hurdles in patients’ way
Amazon still seems to be laissez-faire about enforcement of ingestible hemp-derived cannabinoid products that appear on its site – and in particular those containing intoxicating hemp-derived cannabinoids (IHDCs)
The UK Advertising Standards Authority (ASA) has taken action on CBD product marketing, targeting a series of advertorials produced by Consumer Logic Research specifically promoting two brands
The UK is lagging behind other major markets in the world on research into the benefits of medicinal cannabis, according to a scientist specialising in the area
US president Joe Biden has called for a scheduling review of cannabis. This report will examine the procedure, potential outcomes, and implications of this scheduling review.
Japan has taken a step closer to legalising cannabinoid-based medicines and clarifying restrictions on hemp cultivation, though it is also set to strengthen measures against recreational cannabis use
This report provides a detailed overview of the current regulatory framework in place for hemp, cannabinoids and cannabis, covering everything from processing and cultivation to finished products, import/export and the countries medical and recreational cannabis regime
A recent study has shown that CBD can reduce the psychoactive effects of THC – a discovery which could advance the clinical application of medical cannabis
Unlicensed offline retailers selling IHDC products fall mainly into three categories: smoke shops, vape stores and fuel stations. IHDC product sales outside of these niche retailers have yet to be identified
A Croatian hemp producer is challenging the interpretation used by law enforcement to oppose the sale of hemp flower in the country
This market reports offers a detailed overview of the current market for intoxication hemp-derived cannabinoids in the US, covering all aspects of the market from sizing, consumers and retailers, to brands and formats
A French hemp trade association believes the consortium approach applied in the initial European novel food application process could again be the solution to the requests for extra data that have stalled assessments
As debate over the legalisation of recreational cannabis involves a growing number of European countries, the commercial demand for legal psychoactive alternatives to controlled cannabinoid variants is on the rise
As the US midterm elections approach, questions are being raised about the actions the Biden administration has taken to meet campaign promises regarding drug reform
The countries analysed in this report were specifically selected due to their recent regulatory developments in medical and/or industrial cannabis. These include Eswatini, Ghana, Lesotho, Malawi, Rwanda, Uganda, Zambia and Zimbabwe
This report provides a detailed summary of the current regulations in place for hemp, cannabis and CBD in France, covering all areas from cultivation and processing to extracts and finished products
The right-wing coalition parties which look most likely to triumph in Italy’s coming elections take a uniformly hard line on drug policy – which could be bad news for the cannabinoids industry
Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
